Paper

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.

Published Jul 1, 2016 · R. Carhart-Harris, M. Bolstridge, J. Rucker

The lancet. Psychiatry

961

Citations

Influential Citations

Full text

Semantic Scholar

Abstract

Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Study Snapshot

Key takeawayPsilocybin is a safe and effective treatment for treatment-resistant depression, with marked reductions in depressive symptoms and improvements in anxiety and anhedonia.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.

References

Citations